IRIS
LIAKOULI, Vasiliki
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.353
NA - Nord America 2.872
AS - Asia 2.454
SA - Sud America 653
AF - Africa 31
Totale 11.363
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.978
US - Stati Uniti d'America 2.826
SG - Singapore 869
IE - Irlanda 607
HK - Hong Kong 558
BR - Brasile 556
CN - Cina 522
GB - Regno Unito 238
KR - Corea 177
VN - Vietnam 174
DE - Germania 148
IT - Italia 122
GR - Grecia 113
SE - Svezia 43
AR - Argentina 38
UA - Ucraina 37
IN - India 35
ID - Indonesia 21
TR - Turchia 19
BD - Bangladesh 17
CA - Canada 17
EC - Ecuador 17
CO - Colombia 15
MX - Messico 14
JP - Giappone 13
FI - Finlandia 12
FR - Francia 12
ZA - Sudafrica 12
PY - Paraguay 11
IQ - Iraq 10
NL - Olanda 9
PK - Pakistan 9
UZ - Uzbekistan 8
AT - Austria 7
MA - Marocco 5
VE - Venezuela 5
BE - Belgio 4
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
PE - Perù 4
PL - Polonia 4
CL - Cile 3
CR - Costa Rica 3
EG - Egitto 3
KZ - Kazakistan 3
NP - Nepal 3
SA - Arabia Saudita 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IL - Israele 2
JO - Giordania 2
LV - Lettonia 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BZ - Belize 1
ES - Italia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
RO - Romania 1
SV - El Salvador 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 11.363
Salva come PNG Salva come JPEG
Città #
Moscow 1.316
Dublin 607
Hong Kong 554
Chicago 534
Santa Clara 470
Wilmington 441
Singapore 339
Falls Church 338
Jacksonville 177
Seoul 175
Princeton 110
Roxbury 108
Chandler 103
Bremen 102
Beijing 94
Medford 75
Ho Chi Minh City 68
Hefei 67
Des Moines 41
Hanoi 39
Ashburn 35
Cambridge 35
São Paulo 35
Dallas 25
Naples 25
Rome 23
Bengaluru 19
The Dalles 19
Rio de Janeiro 18
Nanjing 14
New York 14
Belo Horizonte 13
Guangzhou 13
Ann Arbor 12
Jinan 12
Curitiba 11
Guarulhos 11
Brasília 10
Caserta 9
Los Angeles 9
Amsterdam 8
Hangzhou 8
Hebei 8
Munich 8
Ottawa 8
Shenyang 8
Tashkent 8
Tianjin 8
Baghdad 7
Boardman 7
Da Nang 7
Johannesburg 7
Ningbo 7
Salvador 7
Changsha 6
Frankfurt am Main 6
Hải Dương 6
Kunming 6
Santo André 6
Shanghai 6
Thái Bình 6
Athens 5
Bagnoli Irpino 5
Biên Hòa 5
Campinas 5
Caxias do Sul 5
Ciudad del Este 5
Dearborn 5
Falkenstein 5
Guayaquil 5
Lấp Vò 5
Marsico Nuovo 5
Nuremberg 5
Ribeirão Preto 5
Woodbridge 5
Afragola 4
Aparecida de Goiânia 4
Asunción 4
Bogotá 4
Brussels 4
Contagem 4
Fortaleza 4
Haiphong 4
Helsinki 4
Hortolândia 4
Itabira 4
Kingston 4
Kostroma 4
Lahore 4
Montreal 4
Mugnano di Napoli 4
Nairobi 4
Natal 4
Praia Grande 4
San Mateo 4
Seattle 4
Suzano 4
Taizhou 4
Vienna 4
Barbacena 3
Totale 6.437
Salva come PNG Salva come JPEG
Nome #
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 1.376
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 172
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 139
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 138
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 128
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 126
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 121
. FRI0437 Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from SSC Patients Induces an Anti Angiogenetic Effect, when Co-Cultured with Endothelial Cells. 116
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 113
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 113
Association of FASG670A gene polymorphism with systemic sclerosis. 112
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 111
AB0226 Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC). 111
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 110
Angiogenic cytokines and growth factors in systemic sclerosis 109
AB0244 Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 108
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome 107
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 107
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 106
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 102
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 101
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 98
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 97
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 96
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 94
Interstitial lung disease in systemic sclerosis: current and future treatment 92
AB0248 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 92
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 91
Interleukin-33 and its receptor st2 may serve as 'alarmin' system of the progressing damage to the skin and visceral organs of systemic sclerosis (ssc) patients 89
Modificazioni della nitrossido-sintasi neuronale (nNOS) nella cute dei pazienti con sclerosi sistemica (SSc). 87
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 87
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 87
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 87
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 87
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 86
Cardiovascular disease in primary sjögren’s syndrome 86
IMPAIREMENT OF ENDOTHELIAL DIFFERENTIATION FROM MESENCHYMAL STEM CELLS (MSC) IN SYSTEMIC SCLEROSIS (SSC): A NEW TOOL IN PATHOGENETIC MECHANISM 86
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 84
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 84
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 84
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 83
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies 83
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 83
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease. 82
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 81
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 81
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION 81
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 80
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI) 80
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 79
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implication. 79
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis 79
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine 79
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 79
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 78
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 78
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage 78
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 77
SAT0191 Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren's syndrome. 77
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 77
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 76
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy 76
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 75
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 75
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma 75
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients 74
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 74
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 74
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 74
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 74
Methotrexate: an old new drug in autoimmune disease 74
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 74
AI-Based HRCT Quantification in Connective Tissue Disease-Associated Interstitial Lung Disease 73
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 73
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 73
SDF-1 expression in the skin of SSc patients. 73
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 73
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 72
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 72
Tocilizumab for the treatment of adult-onset Still's disease: results from a case series 72
Macitentan inhibits the transforming growth factor-βprofibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts. 72
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 71
Towards a consensus on the clinical applications and interpretations of the nailfold capillaroscopy standards in clinical practice: An initiative by the Egyptian Society of Microcirculation 71
The Vessels Contribute to Fibrosis in Systemic Sclerosis 71
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 71
Use of Rituximab in the Management of Sjögren’s Syndrome 70
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 70
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 69
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients 69
Decreased expression of angiopoietin 1 on perivascular mesenchymalstemcells from SSc patients induces an anti angiogenic effect, when co-cultured with endothelial cells 69
Cellular players in angiogenesis during the course of systemic sclerosis 68
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 68
Pigment epithelium derived factor secreted by ssc fibroblasts inhibits angio and vasculogenesis in vitro. 68
Potential of stem cells in the treatment of rheumatic didease 68
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 67
Endothelial Progenitor Cells (EPC) characterization in systemic sclerosis (SSc) patients. 67
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features 67
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 66
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 66
Development of a core domain set for nailfold capillaroscopy reporting 65
Totale 9.863
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.447
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021248 0 0 0 0 0 2 105 10 12 8 109 2
2021/20221.446 73 133 258 115 322 30 24 25 43 30 84 309
2022/20231.336 206 85 308 14 138 37 0 27 503 2 5 11
2023/2024356 18 9 3 7 160 10 6 12 4 7 9 111
2024/20251.826 1 0 3 31 240 283 292 165 231 395 111 74
2025/20265.908 258 343 425 482 652 3.748 0 0 0 0 0 0
Totale 11.584